| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8444048 | European Journal of Cancer | 2013 | 9 Pages |
Abstract
These studies identify dual targeted inhibitors of PI3K/mTOR in combination with inhibitors of RAS/ERK signalling as a potentially effective new approach to treating ovarian cancer.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Karen E. Sheppard, Carleen Cullinane, Katherine M. Hannan, Meaghan Wall, Joanna Chan, Frances Barber, Jung Foo, Donald Cameron, Amelia Neilsen, Pui Ng, Jason Ellul, Margarete Kleinschmidt, Kathryn M. Kinross, David D. Bowtell, James G. Christensen,